pbpk-qsp-mrgsolve icon indicating copy to clipboard operation
pbpk-qsp-mrgsolve copied to clipboard

Case studies with mrgsolve: PBPK and QSP model implementation and utilization in R

Where / when

  • University at Buffalo
    • 2018 CDSE Days (Buffalo, NY)
    • Tuesday, 10 April 9:30 am to 12:30 pm
  • University of Florida
    • College of Pharmacy (Orlando Lake Nona Campus)
    • Saturday, 24 March 1:30 pm to 5:30 pm

Case Studies

Please see the reading list below for references for the case studies

QSP Models

  • ERK inhibition in BRAF(V600E) mutant colorectal cancer
  • OpenBoneMin: Bone marker and BMD changes under denosumab therapy

PBPK Models

  • PBPK model for rifampicin / midazolam DDI
  • Parameter optimization in PBPK model for statin/CsA DDI

Methods

  • Global sensitivity analysis

Reading List

  • Quantitative Analyses of Hepatic OATP-Mediated Interactions Between Statins and Inhibitors Using PBPK Modeling With a Parameter Optimization Method
  • Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug-Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects
  • Clinical responses to ERK inhibition in BRAF(V600E)-mutant colorectal cancer predicted using a computational model
  • Predicting nonlinear changes in bone mineral density over time using a multiscale systems pharmacology model
  • Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models